Envista Holdings Corporation (NVST)Healthcare | Medical Instruments & Supplies | Brea, United States | NYSE
26.22 USD
+0.31
(1.196%)
⇧
(July 13, 2026, 4 p.m.
EDT)
After hours: 26.37 +0.15 (0.572%) ⇧ (July 13, 2026, 6:22 p.m. EDT) |
Hot Take ↕ | July 11, 2026, 6:29 a.m. EDT
The immediate setup looks like a classic 'value trap' waiting for a catalyst. Fundamentally, the company is showing signs of life with a 14% revenue growth rate and a massive earnings revision upward (EPS jumping from $0.41 to $1.57 forward), which explains why the forward P/E has compressed so sharply relative to the trailing multiple. However, the stock is still technically trapped below its 50-day average, and the statistical forecast model leans slightly negative for the next month, creating a tension between the improving business metrics and the lagging price action. The short-term rating sits at 3.5 because the momentum is building but not yet explosive; the recent price action shows volatility rather than a clean trend, and the statistical model warns of a potential dip. The options market tells a different story, screaming 'bullish' with heavy call buying at the $30 level, which suggests smart money sees the current price as a floor. This divergence creates a high-risk, high-reward scenario: if the earnings beat translates into a sustained price discovery process, the gap between the low forward P/E and the high analyst targets offers significant room to run. However, without a confirmed break above the 50-day moving average, the path of least resistance remains slightly downward in the very short term. Long-term, the picture is much brighter. The multi-year trajectory is no longer a structural decline; the asset has recovered significantly from its lows, and the latest year-on-year performance is positive. The combination of strong revenue growth, expanding margins, and a fortress-like balance sheet (low debt-to-equity) supports a solid buy rating. It is no longer a distressed asset but a turnaround story that has stabilized. The lack of a dividend is irrelevant here; the equity is being reinvested into growth, which is the correct strategy for a company in this phase. Investors should view the current price as a discount to the intrinsic value implied by the forward earnings and the analyst consensus, making it a compelling hold for the medium-to-long term despite the short-term noise. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.075196 |
| AutoETS | 0.084821 |
| AutoARIMA | 0.084943 |
| MSTL | 0.093981 |
| MSTL_126 | 0.097571 |
| MSTL_90_126 | 0.103770 |
| MSTL_90 | 0.107117 |
Forecast horizon: 60 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 47% |
| H-stat | 0.79 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.090 |
| Excess Kurtosis | -1.38 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 51.606 |
| Revenue per Share | 16.929 |
| Market Cap | 4,266,725,888 |
| Trailing P/E | 63.95 |
| Forward P/E | 16.67 |
| Beta | 0.86 |
| Profit Margins | 2.41% |
| Website | https://envistaco.com |
As of July 11, 2026, 6:29 a.m. EDT: Speculators are heavily positioning for upside, evidenced by massive open interest in $30 and $35 calls compared to negligible put volume. The $30 strike acts as a significant barrier where traders are betting on a breakout, while ATM calls show new inflow. Conversely, put activity is sparse and concentrated at lower strikes ($17.50-$20.00), suggesting limited hedging demand and a bullish bias among retail and speculative capital.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.29355967 |
| Address1 | Building E |
| Address2 | 200 South Kraemer Boulevard |
| All Time High | 52.03 |
| All Time Low | 10.08 |
| Ask | 26.32 |
| Ask Size | 400 |
| Audit Risk | 2 |
| Average Analyst Rating | 2.2 - Buy |
| Average Daily Volume10 Day | 2,989,340 |
| Average Daily Volume3 Month | 3,134,913 |
| Average Volume | 3,134,913 |
| Average Volume10Days | 2,989,340 |
| Beta | 0.861 |
| Bid | 26.31 |
| Bid Size | 700 |
| Board Risk | 2 |
| Book Value | 18.904 |
| City | Brea |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 4 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 26.22 |
| Current Ratio | 2.44 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 26.45 |
| Day Low | 25.78 |
| Debt To Equity | 51.606 |
| Display Name | Envista |
| Earnings Call Timestamp End | 1,785,960,000 |
| Earnings Call Timestamp Start | 1,785,960,000 |
| Earnings Growth | 1.3 |
| Earnings Quarterly Growth | 1.15 |
| Earnings Timestamp | 1,785,960,000 |
| Earnings Timestamp End | 1,785,960,000 |
| Earnings Timestamp Start | 1,785,960,000 |
| Ebitda | 383,100,000 |
| Ebitda Margins | 0.13643 |
| Enterprise To Ebitda | 12.459 |
| Enterprise To Revenue | 1.7 |
| Enterprise Value | 4,773,126,144 |
| Eps Current Year | 1.43213 |
| Eps Forward | 1.57319 |
| Eps Trailing Twelve Months | 0.41 |
| Esg Populated | 0 |
| Exchange | NYQ |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 714 817 5450 |
| Fifty Day Average | 24.8602 |
| Fifty Day Average Change | 1.3597984 |
| Fifty Day Average Change Percent | 0.054697804 |
| Fifty Two Week Change Percent | 29.355967 |
| Fifty Two Week High | 30.42 |
| Fifty Two Week High Change | -4.200001 |
| Fifty Two Week High Change Percent | -0.13806708 |
| Fifty Two Week Low | 18.77 |
| Fifty Two Week Low Change | 7.449999 |
| Fifty Two Week Low Change Percent | 0.3969099 |
| Fifty Two Week Range | 18.77 - 30.42 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,568,813,400,000 |
| Float Shares | 162,031,447 |
| Forward Eps | 1.57319 |
| Forward P E | 16.666773 |
| Free Cashflow | 216,337,504 |
| Full Exchange Name | NYSE |
| Full Time Employees | 12,000 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,782,864,000 |
| Gross Margins | 0.55254 |
| Gross Profits | 1,551,600,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.0047999998 |
| Held Percent Institutions | 1.1340001 |
| Implied Shares Outstanding | 162,727,923 |
| Industry | Medical Instruments & Supplies |
| Industry Disp | Medical Instruments & Supplies |
| Industry Key | medical-instruments-supplies |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products, as well as provides DTX Studio Clinic, a software package offered with its imaging products. This segment offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California. |
| Long Name | Envista Holdings Corporation |
| Market | us_market |
| Market Cap | 4,266,725,888 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_629627778 |
| Most Recent Quarter | 1,775,174,400 |
| Net Income To Common | 67,700,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 4,216,280,484 |
| Number Of Analyst Opinions | 14 |
| Open | 25.92 |
| Operating Cashflow | 272,100,000 |
| Operating Margins | 0.09865 |
| Overall Risk | 3 |
| Payout Ratio | 0.0 |
| Phone | 714 817 7000 |
| Post Market Change | 0.15000153 |
| Post Market Change Percent | 0.57208824 |
| Post Market Price | 26.37 |
| Post Market Time | 1,783,981,374 |
| Previous Close | 25.91 |
| Price Eps Current Year | 18.308393 |
| Price Hint | 2 |
| Price To Book | 1.3870081 |
| Price To Sales Trailing12 Months | 1.5194352 |
| Profit Margins | 0.02411 |
| Quick Ratio | 1.932 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 2.1875 |
| Region | US |
| Regular Market Change | 0.309999 |
| Regular Market Change Percent | 1.19645 |
| Regular Market Day High | 26.45 |
| Regular Market Day Low | 25.78 |
| Regular Market Day Range | 25.78 - 26.45 |
| Regular Market Open | 25.92 |
| Regular Market Previous Close | 25.91 |
| Regular Market Price | 26.22 |
| Regular Market Time | 1,783,972,803 |
| Regular Market Volume | 1,703,456 |
| Return On Assets | 0.030079998 |
| Return On Equity | 0.02214 |
| Revenue Growth | 0.144 |
| Revenue Per Share | 16.929 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 5 |
| Shares Outstanding | 162,727,923 |
| Shares Percent Shares Out | 0.060500003 |
| Shares Short | 9,836,917 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 11,848,235 |
| Short Name | Envista Holdings Corporation |
| Short Percent Of Float | 0.0677 |
| Short Ratio | 3.69 |
| Source Interval | 15 |
| State | CA |
| Symbol | NVST |
| Target High Price | 35.0 |
| Target Low Price | 21.0 |
| Target Mean Price | 29.42857 |
| Target Median Price | 30.0 |
| Total Cash | 1,082,800,000 |
| Total Cash Per Share | 6.654 |
| Total Debt | 1,589,200,000 |
| Total Revenue | 2,808,100,096 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 0.41 |
| Trailing P E | 63.951218 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 23.84205 |
| Two Hundred Day Average Change | 2.3779488 |
| Two Hundred Day Average Change Percent | 0.09973759 |
| Type Disp | Equity |
| Volume | 1,703,456 |
| Website | https://envistaco.com |
| Zip | 92,821-6208 |